MX2022004836A - Vacunas mejoradas para la papilomatosis respiratoria recurrente y métodos para su uso. - Google Patents

Vacunas mejoradas para la papilomatosis respiratoria recurrente y métodos para su uso.

Info

Publication number
MX2022004836A
MX2022004836A MX2022004836A MX2022004836A MX2022004836A MX 2022004836 A MX2022004836 A MX 2022004836A MX 2022004836 A MX2022004836 A MX 2022004836A MX 2022004836 A MX2022004836 A MX 2022004836A MX 2022004836 A MX2022004836 A MX 2022004836A
Authority
MX
Mexico
Prior art keywords
methods
same
disclosed
improved vaccines
recurrent respiratory
Prior art date
Application number
MX2022004836A
Other languages
English (en)
Inventor
David B Weiner
Jian Yan
Original Assignee
Inovio Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inovio Pharmaceuticals Inc filed Critical Inovio Pharmaceuticals Inc
Publication of MX2022004836A publication Critical patent/MX2022004836A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se divulga el uso de inmunógenos anti-HPV y moléculas de ácido nucleico que los codifican para el tratamiento y prevención de RRP. Se divulgan una composición farmacéutica, vacunas recombinantes que comprenden plásmidos de ADN y vacunas vivas atenuadas, así como métodos para inducir una respuesta inmunitaria para tratar o prevenir RRP.
MX2022004836A 2019-10-24 2020-10-26 Vacunas mejoradas para la papilomatosis respiratoria recurrente y métodos para su uso. MX2022004836A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962925283P 2019-10-24 2019-10-24
PCT/US2020/057314 WO2021081480A2 (en) 2019-10-24 2020-10-26 Improved vaccines for recurrent respiratory papillomatosis and methods for using the same

Publications (1)

Publication Number Publication Date
MX2022004836A true MX2022004836A (es) 2022-07-19

Family

ID=75620849

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004836A MX2022004836A (es) 2019-10-24 2020-10-26 Vacunas mejoradas para la papilomatosis respiratoria recurrente y métodos para su uso.

Country Status (10)

Country Link
US (1) US20230000969A1 (es)
EP (1) EP4048682A4 (es)
JP (1) JP2022554132A (es)
KR (1) KR20220114531A (es)
CN (1) CN115443287A (es)
AU (1) AU2020371792A1 (es)
BR (1) BR112022007615A2 (es)
CA (1) CA3155370A1 (es)
MX (1) MX2022004836A (es)
WO (1) WO2021081480A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240123052A1 (en) * 2022-10-13 2024-04-18 Inovio Pharmaceuticals, Inc. Vaccines For Recurrent Respiratory Papillomatosis And Methods of Using the Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833754B2 (en) * 2006-01-13 2010-11-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services IL-12 for expression in mammalian cell
KR102373828B1 (ko) * 2011-10-12 2022-03-14 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법
CN103555734B (zh) * 2012-09-17 2015-07-15 青岛康立泰药业有限公司 人白细胞介素-12的编码基因、真核宿主细胞和表达方法
JP6517779B2 (ja) * 2013-03-12 2019-05-22 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ヒトパピローマウイルスの改良型ワクチンおよびその使用方法

Also Published As

Publication number Publication date
BR112022007615A2 (pt) 2022-07-12
CA3155370A1 (en) 2021-04-29
EP4048682A4 (en) 2023-11-01
EP4048682A2 (en) 2022-08-31
AU2020371792A1 (en) 2022-06-09
CN115443287A (zh) 2022-12-06
WO2021081480A2 (en) 2021-04-29
JP2022554132A (ja) 2022-12-28
KR20220114531A (ko) 2022-08-17
WO2021081480A3 (en) 2021-06-03
US20230000969A1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
ZA202002094B (en) Trispecific proteins and methods of use
MX2019006045A (es) Proteinas triespecificas dirigidas a psma y metodos de uso.
MX2017014908A (es) Proteinas de union triespecificas y metodos de uso.
MX2022004786A (es) Variante de aav2 con aflibercept para usarse en el tratamiento de una condicion o enfermedad ocular.
MX2021014007A (es) Proteinas de union a epcam y metodos de uso.
MX2018006840A (es) Focalizacion de peptidos para dirigir virus adenoasociados.
PH12017500614A1 (en) Compositions and methods for silencing hepatitis b virus gene expression
MX359953B (es) Ácido nucleico que comprende o que codifica un tallo-rizo de histona y una secuencia poli (a) o una señal de poliadenilación para incrementar la expresión de una proteína terapéutica codificada.
BR112016024352A2 (pt) ?cepa de listeria recombinante, listeria recombinante, composição farmacêutica, e, métodos de induzir uma resposta imune contra um tumor ou um câncer em um indivíduo humano e de listeria?
MX2020001385A (es) Composiciones que comprenden construcciones geneticas y vacunas de il-12 mejoradas, agentes inmunoterapeuticos y metodos para su uso.
WO2017214596A8 (en) Compositions and methods for preventing and treating zika virus infection
MX2022000453A (es) Compuestos útiles para tratar infecciones por virus de influenza.
MX2018005286A (es) Constructo genetico.
MX2011007692A (es) Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion.
EA201992282A1 (ru) Усовершенствованные вакцины против вируса папилломы человека и способы их применения
MX2018015110A (es) Arn modificado que codifica polipeptidos de vegf-a. formulaciones y usos relacionados con los mismos.
MX2017010908A (es) Vacuna bivalente contra el virus de gripe porcina.
EA202090700A1 (ru) Компетентные по репликации аденовирусные векторы
MX2022002315A (es) Anticuerpos anti-cd96 y sus metodos de uso.
CO2022017989A2 (es) Vacunas para la papilomatosis respiratoria recurrente y métodos para usar estas
MX2021005980A (es) Adenovirus y metodos para usar adenovirus.
MX2018005872A (es) Profarmacos de acido nucleico.
WO2021202949A3 (en) Compositions and methods for treating vulvar dysplasia
PH12017501100A1 (en) Recombinant swinepox virus and vaccines
WO2020079489A3 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs